Supervalue Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 1.00 M
as on 24-10-2024
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 Cr
as on 24-10-2024
- Revenue -3.16%
(FY 2023)
- Profit 20.99%
(FY 2023)
- Ebitda 24.39%
(FY 2023)
- Net Worth 46.64%
(FY 2023)
- Total Assets 17.76%
(FY 2023)
About Supervalue Pharmacy
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.50 Cr.
Vijesh Mohan, Chand Khan, and Aisha Khan serve as directors at the Company.
- CIN/LLPIN
U74120UP2014PTC064799
- Company No.
064799
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jul 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Supervalue Pharmacy?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijesh Mohan  | Whole-Time Director | 09-Jul-2014 | Current |
| Chand Khan | Whole-Time Director | 09-Jul-2014 | Current |
| Aisha Khan | Whole-Time Director | 03-Jan-2020 | Current |
Financial Performance of Supervalue Pharmacy.
Supervalue Pharmacy Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.16% decrease. The company also saw a substantial improvement in profitability, with a 20.99% increase in profit. The company's net worth Soared by an impressive increase of 46.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Supervalue Pharmacy?
In 2023, Supervalue Pharmacy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lucknow Esamudaay Digital Services Private LimitedActive 2 years 6 monthsVijesh Mohan is a mutual person
- Esamudaay India Digital Distribution Private LimitedActive 2 years 6 months
Vijesh Mohan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 28 Mar 2023 | ₹1.45 Cr | Open |
Hdfc Bank Limited Creation Date: 09 Jan 2023 | ₹1.05 Cr | Open |
How Many Employees Work at Supervalue Pharmacy?
Unlock and access historical data on people associated with Supervalue Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Supervalue Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supervalue Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
